Results 271 to 280 of about 60,320 (281)

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly  

Exploring Collegiate Athlete Use Of Caffeine, Supplements, And Current Mental Health On Disordered Eating

Medicine & Science in Sports & Exercise
Stephen Michael Cirella, Eamonn M. O'Connell, Nicole E. Logan, Christie L. Ward-Ritacco, Mark E. Hartman, Disa L. Hatfield   +5 more
openaire   +1 more source

Lactate response to caffeine in panic disorder: a replication using an “anxious” control group

Biological Psychiatry, 1991
openaire   +1 more source

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2018
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis

Yearbook of Psychiatry and Applied Mental Health, 2008
openaire   +1 more source

[Use of the methylxanthines, caffeine and theophylline, in the treatment of extrapyramidal disorders caused by treatment with neuroleptics. Development of a therapeutic hypothesis].

L'Encephale, 1989
M, Casas, M, Torrens, P, Duro, C, Pinet, E, Alvarez, C, Udina   +5 more
openaire   +1 more source